𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) Angiographic Substudy

✍ Scribed by Yuri B. Pride; Satishkumar Mohanavelu; Cafer Zorkun; Vijayalakshmi Kunadian; Robert P. Giugliano; L. Kristin Newby; Eugene Braunwald; Robert M. Califf; Robert A. Harrington; C. Michael Gibson

Book ID
119289533
Publisher
American College of Cardiology
Year
2012
Tongue
English
Weight
385 KB
Volume
5
Category
Article
ISSN
1936-8798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Early Glycoprotein IIb/IIIa Inhibiti
The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale
✍ Robert P. Giugliano; L. Kristin Newby; Robert A. Harrington; C. Michael Gibson; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB
Efficacy and safety of enoxaparin compar
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
✍ Harvey D. White; Neal S. Kleiman; Kenneth W. Mahaffey; Yuliya Lokhnygina; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 333 KB